Hoover Institution Launches Bio-Leadership Summit (BLISS) at Stanford University

Hoover Institution (Stanford, CA) - The Hoover Institution's Bio-Strategies and Leadership (BSL) Initiative convened more than 350 leaders from academia, government, nonprofits, and industry at Stanford University on April 14, 2026, for the inaugural Bio-Leadership Summit (BLISS).

The one-day summit aimed to elevate biotechnology culturally and politically to the level of energy or AI and to pressure test what leadership should look like in an increasingly biotic future.

Biotechnology was integrated throughout the summit, including environmental biosensing technology from SafeTraces, whose real-time pathogen sampler ran throughout the event and ultimately returned an all-clear reading. Bioengineered food products such as purple tomatoes enriched with naturally occurring antioxidants were also featured.

The summit program included panels, briefings, and remarks on biotechnology's applications across health, security, and the economy.

In her opening remarks, Hoover Institution Director and former secretary of state Condoleezza Rice emphasized the importance of engaging both the risks and opportunities of biotechnology as a frontier technology.

In his remarks, Hoover Institution Science & Senior Fellow and BSL head Drew Endy underscored both the urgency and the inevitability of the moment, noting that "every day matters." Endy emphasized that biotechnology will continue to advance with or without deliberate direction, making leadership a central challenge of the current era. "Biotechnology will shape the future regardless," he said. "The question is whether we have the courage to put our hand on the rudder and steer the ship."

Additional speakers included Zack Abbott of ZBiotics, maker of a genetically engineered probiotic designed to be taken before drinking alcohol, and Keith Wood of LightBio, known for his company's bioluminescent petunias. These sessions made clear that consumer-facing biotechnology products may be one of the most direct ways to build public familiarity and trust in the field.

Participants also received briefings on two cutting-edge aspects of biotechnology: synthetic cells and generative biology. Kate Adamala outlined efforts to build fully programmable cells from first principles while Brian Hie described how AI models trained on genomic data are beginning to design novel genes and even entire genomes. These advances and others suggest a shift toward making biology increasingly engineerable.

Morning panels brought together leaders from Stanford, ARPA-H, Flyttr, and the Chan Zuckerberg Initiative to discuss how biology can improve human and animal health. One example discussed was the growing threat of New World screwworm, where biotechnology is being deployed in partnership with government to develop countermeasures to protect livestock and food security in the United States.

Other conversations focused on biosecurity and national security. One idea came up repeatedly: The best way to secure biology is to lead in it.

Later in the day, participants heard from featured industry leaders from Twist Bioscience, FutureHouse, Neion Bio, Antheia, ADM, and Genoa Ventures, who examined the challenges and opportunities of the growing bioeconomy and the role of policy in supporting responsible growth and long-term competitiveness. Speakers were direct about what the moment demands, with one noting that seizing the bioeconomy opportunity will require "radical new ideas and the appetite to invest in those ideas" from government.

Ensuring biotechnology works for all emerged as another core theme. A fireside briefing led by Hoover Institution Senior Fellow Stephen Kotkin in conversation with Drew Endy explored biotechnology as a potential ally of democratic systems. A panel titled "Bio-Opportunities Across the Nation" examined how biotechnology can support job creation and national security, provided states invest and education systems adapt.

Closing remarks emphasized both urgency and optimism, highlighting biotechnology as a transformative force with the potential to reshape economic opportunity, national security, and human well-being.

The summit underscored the need for sustained public and private investment, stronger coordination, and policies responsive to rapid technological change. BLISS reflects BSL's broader mission to advance bio-literacy, inform policy, and support the responsible development and deployment of biotechnology. The BSL team plans to host BLISS on a biennial basis moving forward.

For more information about Bio-Strategies and Leadership, visit victory.stanford.edu or contact Sarah Moront at [email protected].